Effective depression treatment could improve opioid cessation
Research published in the British Journal of Psychiatry has shown that opioid cessation may be more successful if concomitant depression is also effectively treated
Chronic prescription opioid use and depression in patients with non-cancer pain are mutually reinforcing, but research has not previously looked at whether treating depression improves the likelihood of chronic users achieving opioid cessation.
To explore, researchers studied data on 2,821 adults with non-cancer, non-HIV pain, with a new episode of depression following more than 90 days of opioid use, and who received at least one prescription for antidepressant medication.
At 24 weeks, those who adhered to their antidepressant medication (>80% of days covered) were more likely to stop continuous opioid use, which was defined as a gap of at least 182 days from the end-date of the last opioid prescription (57.2 vs 45.0/1,000 person-years; P=0.007). Antidepressant adherence equated to a 24% greater odds of opioid cessation.
Reporting in the British Journal of Psychiatry (1 February 2018), the researchers said the results indicated that opioid cessation may be more successful if concomitant depression is treated to remission.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204611
Recommended from Pharmaceutical Press
Effectively communicate scientific and medical information with The Complete Guide to Medical Writing.£27.00
An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.£54.00
Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.£81.00
Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.£38.00
A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.£54.00